Global Human Organoids Market Size, Trends & Analysis - Forecasts to 2026 By Type of Organ Model (Pancreas, Kidney, Lung, GIT and Liver Model), By Product Use (Customized Models and Readily Available Models), By Application (Developmental Biology, Drug Efficacy & Drug Toxicity, Pathological Studies, and Personalized & Regenerative Drug Research), By End-User (Pharmaceutical & Biotechnology Firms, Contract Research Organizations and Academic Institutes), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis and Competitor Analysis
Witnessing the pandemic ill effects, and rising incidence of human diseases and infections across the globe, many researchers conduct clinical trials of the novel drugs and vaccines on the animal-based model as proofreading methodology. However, with the augment of human Organoids, the market will be seeing a replacement of animal models, and researchers would be able to conduct drug trials for humans on a human-like organ model for better research analysis and drug reaction. Another major reason for replacing animal models is that they do not generate fruitful results during drug toxicity testing, and provide confusing inference for other drug reactions and results. Moreover, over the years, regulations and government laws have restricted the use of animals for any kind of research activities. Human Organoids are models that mimic few organs which have raw materials derived from human cells and tissues. They have the power to represent exact human physiology. Stem cells used to develop an organoid are adult & pluripotent stem cells.
The market will grow exponentially high with the entrance of highly prominent, potential, and innovative start-up firms and companies. These innovators will be the driving force of the market and ultimately help the end-users adopt Organoids faster due to the company’s aggressive organic and inorganic growth activities. Furthermore, advancements associated with drug discovery activity, classic replacement of animal model-based research, increases cases of organ transplants, and increasing interest of the government and private equity firms for financing R&D activities related to human model-based research findings are some of the prime reasons for the market to grow positively during 2020-2026.
Based on the type of organ model, the market is segregated into Pancreas, Kidney, Lung, GIT, and Liver Model. With the increasing number of liver associated diseases, rising consumption of alcohol, diabetes, and obesity, the market is witnessing the rising need to address the liver associated damages. Liver transplant is one of the treatments suggested to the patient with liver failure of any kind of cirrhosis. Hence, considering the rising demand, and success rate of liver transplant amongst other organs, the market for the liver model is definitely on the rise.
Based on the usability of the organ models, the market is segmented into customized and readily available products. Readily available Organoids will dominate the market owing to technical advantages and quick market availability as compared to the customized organoids,
Based on the uses of this technology, the market can be segmented into developmental biology, drug efficacy & drug toxicity, pathological studies, and personalized & regenerative drug research. The largest shareholder in the market would be the developmental biology application. Advancements witnessed in the field of 3D and 4D printing have led this segment to be the dominant one.
Based on the end-user analysis, the market can be segmented into pharmaceutical & biotechnology firms, contract research organizations, and academic institutes. Pharmaceutical and biotech companies are the largest end-users for such products. This is attributed to the increasing number of research activities related to drug testing and drug toxicity testing conducted and hosted by top pharma companies.
Having the highest number of pharmaceutical and biotech companies, and with great penetration power of the human organoid technology in the North American region, the market is going to be the major contributor in terms of revenue. On the other hand, the market for the Asia Pacific will be the fastest-growing mainly due to the increasing number of research activities hosted by Asian-based CROs and the rising incidence of liver diseases, diabetes, and obesity.
Thermo Fisher Scientific, Corning, ZenBio, Organovo, Emulate, Cyprio, Hµrel Corporation, BioIVT, Kerafast, CELLINK, InSphero, Biopredic International, Kirkstall and MIMETAS among others are the major companies in the market.
Please note: This is not an exhaustive list of companies profiled in the report.
In July 2019, Organovo showcased and presented itself & its information and data on fabricating stem cell-based kidney tissues at The International Society for Stem Cell Research 2019 Annual Meeting in the US.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Human Organoids Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Human Organoids Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?